Round co-led by BGF, Octopus Ventures and M Ventures, with support from new corporate investor, Eli Lilly and Company, and existing investors, IQ Capital and Meltwind Appointment of Edwin Moses as Chairman to support the leadership team in maximising the value of the technology platform Novel “nanosyringe” platform can deliver complex biologic payloads selectively and […]
Read more
Our CEO Joe Healey was recently invited to write a piece for Cell Trends’ “Industry Highlights”, which is now available online here. These articles offer short reads about up and coming companies and technologies that are making waves in the industry. NanoSyrinx is delighted to have had the opportunity to tell our story. The article […]
Read more
In 2023, the UK Government published the “National Vision for Engineering Biology”. The report highlighted the ambitions of the UK to be a world leader in the Engineering Biology (a.k.a. Synthetic Biology) sector, and described how £2BN would be put to work over the next decade, cementing the UK’s position at the front of the […]
Read more